Increased release of excitatory amino acids in rat locus coeruleus in κ-opioid agonist dependent rats precipitated by nor-binaltorphimine

Brain Research

Volumn 753, Issue 1, 1997, Pages 63-68

  Hoshi, Katsuji ^a   Ma, Tangeng ^a   Oh, Seikwan ^a   Ho, Ing K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

aspartate; butorphanol; glutamate; locus coeruleus; microdialysis; morphine; nor binaltorphimine; U 69,593

Indexed keywords

BUTORPHANOL; EXCITATORY AMINO ACID; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG WITHDRAWAL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT;

ANIMALS; BENZENEACETAMIDES; BUTORPHANOL; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACIDS; LOCUS COERULEUS; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0030940207     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01492-8     Document Type: Article

References (28)

1. Abdelhamid, E.E., Sultana, M., Portoghese, P.S. and Takemori, A.E., Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice, J. Pharmacol. Exp. Ther., 258 (1991) 299-303.
2. Aghajanian, G.K., Kogan, J.H. and Moghaddam, B., Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study, Brain Res., 636 (1994) 126-130.
3. Akaoka, H. and Aston-Jones, G., Opiate withdrawal-induced hyper-activity of locus coeruleus neurons in substantially mediated by augmented excitatory amino acid input, J. Neurosci., 11 (1991) 3830-3839.
4. Aston-Jones, G., Ennis, M., Pieribone, V.A., Nickell, W.T. and Shipley, M.T., The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network, Science 234 (1986) 734-737.
5. Atweh, S.F. and Kuhar, M.J., Autoradiographic localization of opiate receptors in rat brain. II. The brain stem, Brain Res., 129 (1977) 1-12.
6. Butelman, E.R., Negus, S.S., Al, Y., de Costa, B.R. and Woods, J.H., Kappa-opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys, J. Pharmacol. Exp. Ther., 267 (1993) 1259-1276.
7. Butelman, E.R., Winger, G., Zernig, G. and Woods, J.H., Butorphanol: Characterization of agonist and antagonist effects in rhesus monkeys, J. Pharmacol. Exp. Ther., 272 (1995) 845-853.
8. Ellison, D.W., Beal, M.F. and Martin, J.B., Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection, J. Neurosci. Methods, 19 (1987) 305-315.
9. Feng, Y.Z., Zhang, T., Rockhold, R.W. and Ho, I.K., Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat, Neurochem. Res., 20 (1995) 745-751.
10. 3H] CTOP binding to mu opioid receptors in rat brain, Life Sci., 42 (1988) 2541-2551.
11. Hoshi, K., Ma, T. and Ho, I.K., Precipitated κ-opioid agonist withdrawal increases glutamate in rat locus coeruleus, Eur. J. Pharmacol., 314 (1996) 301-306.
12. Horan, P. and Ho, I.K., The physical dependence liability of butorphanol: a comparative study with morphine, Eur. J. Pharmacol., 203 (1991) 387-391.
13. Jaw, S.P., Hoskins, B. and Ho, I.K., Opioid antagonist and butorphanol dependence, Pharmacol. Biochem. Behav., 44 (1993) 497-500.
14. Leander, J.D., A kappa opioid effect: increased urination in the rat, J. Pharmacol. Exp. Ther., 224 (1983) 89-94.
15. Miyamoto, T. and Okada, Y., NMDA receptor, protein kinase C and calmodulin system participate in the long-term potentiation in guinea pig superior colliculus slices, Brain Res., 605 (1993) 287-292.
16. Miyamoto, Y., Portoghese, P.S. and Takemori, A.E., Involvement of delta 2 opioid receptors in the development of morphine dependence in mice, J. Pharmacol. Exp. Ther., 264 (1993) 1141-1145.
17. Mosaddeghi, M., Kapusta, D.R., Minor, L.D., Duan, N. and Paul, D., Effects of κ-opioid receptor agonists on stimulated phosphoinositide hydrolysis in rat kidney, Eur. J. Pharmacol., 289 (1995) 411-417.
18. Olsson, Y., Sharma, H.S., Nyberg, F. and Westman, J., The opioid receptor antagonist naloxone influences the pathophysiology of spinal cord injury. In F. Nyberg, H.S. Sharma and Z. Wiesenfeld-Hallin (Eds.), Elsevier Science B.V., Amsterdam, Netherlands, 104, 1995, pp. 381-399.
19. Pasternak, G.W., Review: pharmacological mechanisms of opioid analgesics, Clin. Neuropharmacol., Vol. 16, Raven Press, Ltd., New York, 1993, p. 1.
20. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edition, Academic Press Inc., Orlando, FL, 1986.
21. Picker, M.J. and Dykstra, L.A.., Discriminative stimulus effect of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists, J. Pharmacol. Exp. Ther., 249 (1989) 557-566.
22. Randic, M., Cheng, G. and Kojic, L., κ-Opioid receptor antagonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord, J. Neurosci., 15 (1995) 6809-6826.
23. Rasmussen, K., Afferent effect on lucus coeruleus in opiate withdrawal: neurobiology of the locus coeruleus. In C.D. Barnes and O. Pompeiano (Eds.), Progress in Brain Research, Vol. 88, Elsevier Science Publishers B.V., Amsterdam, Netherlands, 1991, pp. 207-216.
24. Rasmussen, K. and Aghajanian, G.K., Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis, Brain Res., 505 (1989) 346-350.
25. Rasmussen, K., Beitner-Johnson, D.B., Krystal, J.H., Aghajanian, G.K. and Nestler, E.J., Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates, J. Neurosci., 10 (1990) 2308-2317.
26. Takemori, A.E., Ho, B.Y., Naeseth, J.S. and Portoghese, P.S., Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays, J. Pharmacol. Exp. Ther., 246 (1988) 255-258.
27. Yasuda, K., Raynor, K., Kong, H., Breder, C.D., Takeda, J., Reisine, T. and Bell, G.I., Cloning and functional comparison of K and δ opioid receptors from mouse brain, Proc. Natl. Acad. Sci. USA, 90 (1993) 6736-6740.
28. Zhang, T., Feng, Y., Rockhold, R.W. and Ho, I.K., Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat, Life Sci., 55 (1994) PL25-31.